End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
290 TWD | +1.58% | -10.22% | +6.62% |
Sales 2024 * | 18.82B 581M | Sales 2025 * | 21.2B 655M | Capitalization | 76.7B 2.37B |
---|---|---|---|---|---|
Net income 2024 * | 4.84B 150M | Net income 2025 * | 6.2B 191M | EV / Sales 2024 * | 4.38 x |
Net Debt 2024 * | 5.71B 176M | Net Debt 2025 * | 1.56B 48.27M | EV / Sales 2025 * | 3.69 x |
P/E ratio 2024 * |
15.4
x | P/E ratio 2025 * |
12.6
x | Employees | 1,099 |
Yield 2024 * |
1.87% | Yield 2025 * |
2.63% | Free-Float | 48.47% |
Latest transcript on Lotus Pharmaceutical Co., Ltd.
1 day | -4.83% | ||
1 week | -11.61% | ||
Current month | -11.61% | ||
1 month | -10.08% | ||
3 months | +3.63% | ||
6 months | +17.25% | ||
Current year | +4.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-09-28 | |
I ling Tian
DFI | Director of Finance/CFO | - | 16-10-31 |
Ying Ming Yue
COO | Chief Operating Officer | - | 22-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 14-08-10 | |
Director/Board Member | 61 | 15-04-22 | |
Han Fei Lin
BRD | Director/Board Member | - | 16-06-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 0 M€ | +3.30% | - | |
0.00% | 0 M€ | +2.91% | - | |
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 290 | +1.58% | 4 015 246 |
24-05-07 | 285.5 | -4.83% | 10,082,560 |
24-05-06 | 300 | -2.44% | 4,912,211 |
24-05-03 | 307.5 | -3.00% | 5,267,458 |
24-05-02 | 317 | -1.86% | 3,453,314 |
End-of-day quote Taiwan S.E., May 06, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.96% | 2.33B | |
+33.13% | 700B | |
-4.77% | 358B | |
+19.63% | 330B | |
+3.61% | 287B | |
+16.19% | 236B | |
+6.76% | 202B | |
-9.16% | 197B | |
+4.66% | 161B | |
-3.07% | 157B |
- Stock Market
- Equities
- 1795 Stock